Skip to main content

Table 3 Rs3733591 and tophaceous gout in the Māori, EP, WP and NZ Caucasian casesa

From: The SLC2A9 nonsynonymous Arg265His variant and gout: evidence for a population-specific effect on severity

  Tophaceous cases, n(OR) Nontophaceous cases, n(OR)     
Sample set CC CT TT C-allele frequency CC CT TT C-allele frequency Genotypic P Allelic P P STRAT Allelic OR, C allele (95% CI)
Māori 36 (0.692) 13 (0.250) 3 (0.058) 0.817 37 (0.446) 37 (0.446) 9 (0.108) 0.669 0.02 0.008 0.01 2.21 (1.22 to 4.01)
EP 43 (0.652) 17 (0.258) 6 (0.091) 0.780 48 (0.490) 41 (0.418) 9 (0.092) 0.699 0.09 0.10 0.17 1.53 (0.92 to 2.55)
WP 22 (0.234) 46 (0.489) 26 (0.277) 0.479 16 (0.213) 41 (0.547) 18 (0.240) 0.487 0.76 0.88 0.54 0.97 (0.63 to 1.48)
NZ Caucasian 63 (0.656) 30 (0.313) 3 (0.031) 0.812 158 (0.715) 57 (0.258) 6 (0.027) 0.844 0.58 0.33 - 0.88 (0.51 to 1.24)
  1. aCI, confidence interval; OR, odds ratio; CI, confidence interval; EP, Eastern Polynesian; NZ, New Zealand; WP, Western Polynesian; PSTRAT = STRAT test for association.